08 Jul 2009 Vical TransVax(tm) CMV Vaccine Achieves Promising Interim Clinical Results in Phase 2 Trial
07 Jul 2009 ImmunoVaccine Technologies to Develop Pseudomonas Vaccine from Yokohama City University
07 Jul 2009 Landmark study for GSK’s cervical cancer vaccine published in The Lancet
06 Jul 2009 Oxford Biomedica Announces Outcome of FDA Review And Updates On Trovax® Phase III Trist Study In Renal Cancer
30 Jun 2009 Vical H1 Influenza Vaccine Delivers Robust Preclinical Results With 100% Response
30 Jun 2009 Medicago's vaccine candidate against novel influenza A (H1N1) virus immunogenic in mice
30 Jun 2009 Novartis receives Complete Response letter from the US Food and Drug Administration for its investigational vaccine Menveo
29 Jun 2009 Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery, Inc.
25 Jun 2009 Apthera Receives Special Protocol Assessment (SPA) From FDA for Pivotal Phase III Trial of NeuVax in Early-Stage Breast Cancer
24 Jun 2009 Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
22 Jun 2009 Merck Initiates Phase III Study of Stimuvax in Breast Cancer
22 Jun 2009 Néovacs to Expand Clinical Testing of Its TNF-alpha Kinoid Lead Product Candidate Following Positive Preliminary Findings from a Phase I/II Study
22 Jun 2009 Positive Phase I Trial Results for Pevion Biotech’s and Bio Life Science’s Breast Cancer Vaccine
19 Jun 2009 Avir Green Hills: Excellent Preclinical Data on Novel Type of Intranasal H5N1 Influenza Vaccine
19 Jun 2009 Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy
17 Jun 2009 Antigenics' QS-21 Adjuvant Enters Pivotal Phase 3 Clinical Trial of GlaxoSmithKline's Malaria Vaccine
17 Jun 2009 VaxInnate Reports Positive Results from Preclinical Testing of Swine Flu Vaccine Developed Using Novel Technology
15 Jun 2009 Advaxis Clinical Trial Survival Data Significantly Exceeds the National Cancer Institute's Median Survival Statistic
15 Jun 2009 Baxter Advances to Full-Scale Production of A/H1N1 Vaccine
12 Jun 2009 Novartis successfully demonstrates capabilities of cell-based technology for production of A(H1N1) vaccine
11 Jun 2009 New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
11 Jun 2009 Genetic Immunity, InPlay: Company Completes Patient Enrollment in Phase II Trial of DermaVir Patch HIV Immunotherapeutic Nanomedicine Lead Product Candidate
11 Jun 2009 Cytos Biotechnology initiates combined phase I/IIa study with a novel anti-interleukin-1 beta vaccine in patients with type II diabetes mellitus
10 Jun 2009 Bayhill Therapeutics Enters Exclusive, Worldwide Collaboration with Genentech for BHT-3021 in Type 1 Diabetes
04 Jun 2009 Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up